Comprehensive National PrEP Bills to Prevent HIV Introduced

We thank the leadership of Sens. Smith and Schiff and Reps. Takano, Balint and Pocan in reintroducing the PrEP Access and Coverage Act. Passage of this bill will greatly expand access to PrEP for people who have health coverage across all payers and create a national grant program that includes community and provider outreach as well as PrEP drugs and associated services for the uninsured. We have a national HIV treatment program, but in order to end HIV, we need a comprehensive national HIV PrEP program.
See the press release

Congress Funds Domestic HIV Programs—Trump Administration Must Now Implement Them

After a tumultuous year of proposed program cuts and eliminations, Congress has agreed to reject them and instead has maintained funding for domestic HIV prevention and treatment programs on a bipartisan basis. Now, the Trump administration must focus its attention on properly implementing these programs in order to get the nation back on track to end HIV in the U.S.
See the press release

CVS Health Decides to Cover New Long-Acting PrEP Drug

We are pleased that CVS Health has finally decided to cover this groundbreaking new PrEP medication. Four months ago, 63 HIV organizations joined us in sending a letter to CVS’s president urging them to reconsider their refusal to cover Yeztugo and reminding them of their legal obligation to cover PrEP and describe the important benefits the drug would bring to preventing HIV in the US. With this coverage decision, CVS joins other leading payers and PBMs in covering the new medication
See the press release

Two Years After Court Victory, Patients Still Saddled with Unaffordable Drug Costs

For the sake of millions of patients who rely on copay assistance to afford their prescription drugs, it is long past time for the federal government to comply with the Court: either require insurers to comply with the current rule that allows copay assistance to count in most instances or issue a new cost-sharing rule. We know President Trump wants to lower how much Americans pay for their drugs, especially compared to other nations, and requiring copay assistance to count will lower patients’ costs and reduce profiteering by drug middlemen.
See the press release

Sens. Cassidy & Van Hollen Introduce Historic Bill to Eliminate Hepatitis C

We deeply thank Chairman Cassidy and Senator Van Hollen for their bipartisan leadership and dedication to eliminating hepatitis C. This bill, if enacted, will finally provide the necessary resources to ensure that more people are diagnosed and linked to no-cost treatment so that we can eventually eliminate hepatitis C.
See the press release

Eighty Advocacy Organizations Urge Labor Secretary to Close Harmful EHB Loophole

The HIV+Hepatitis Policy Institute, along with more than 75 organizations representing patients, providers, and public health advocates, is urging U.S. Secretary of Labor Lori Chavez-DeRemer to issue a promised federal rule that would close a harmful loophole that allows insurers, pharmacy benefit managers (PBMs), and third-party vendors to exploit patient copay assistance programs for financial gain.
See the press release

Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Key Issues

Causes We Care About, and So Should You!

HIV

Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

Learn More

Facebook posts by @HIV+Hep

Tweets by @HIV+Hep

Pin It on Pinterest